The integration of cancer biomarkers allowing remarkable advancements in cancer therapeutics
Jean-Charles Soria shared a post on Linkedin:
” The integration of cancer biomarkers has revolutionized cancer treatment, allowing remarkable advancements in cancer therapeutics and the prognosis of cancer patients. This review paints the road ahead.”
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
Authors: Antonio Passaro, Maise Al Bakir, Emily G. Hamilton, Maximilian Diehn, Fabrice Andre, Sinchita Roy-Chowdhuri, Giannis Mountzios, Ignacio I. Wistuba, Charles Swanton, Solange Peters.
Source: Jean-Charles Soria/Linkedin
Jean-Charles Soria serves as Amgen’s senior vice president of Oncology within Global Development. He is a medical oncologist and a professor of medicine at Paris-Saclay University. From 2017 to 2019, he was the senior vice president of Research and Development in Oncology at AstraZeneca. Additionally, Soria has authored or co-authored over 670 articles in leading international journals and has been recognized as one of the world’s most influential research scientists.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023